Dantrolene prevents ventricular tachycardia by stabilizing the ryanodine receptor in pressure- overload induced failing hearts
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 521 (1) , 57-63
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 22 references indexed in Scilit:
- Ca 2+ /Calmodulin-Dependent Protein Kinase II and Protein Kinase A Differentially Regulate Sarcoplasmic Reticulum Ca 2+ Leak in Human Cardiac PathologyCirculation, 2013
- Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the Ryanodine ReceptorCirculation Research, 2010
- Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca2+ release in heart failureCardiovascular Research, 2010
- Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunctionBiochemical and Biophysical Research Communications, 2010
- Requirement for Ca2+/calmodulin–dependent kinase II in the transition from pressure overload–induced cardiac hypertrophy to heart failure in miceJournal of Clinical Investigation, 2009
- Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Markedly Improves the Function of Failing Cardiomyocytes by Stabilizing Interdomain Interactions Within the Ryanodine ReceptorJACC, 2009
- Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing HeartsCirculation, 2008
- Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channelJournal of Clinical Investigation, 2007
- Free and bound intracellular calmodulin measurements in cardiac myocytesCell Calcium, 2007
- Defective Regulation of Interdomain Interactions Within the Ryanodine Receptor Plays a Key Role in the Pathogenesis of Heart FailureCirculation, 2005